Venetoclax with dexamethasone for treating relapsed or refractory t(11;14)-positive multiple myeloma after lenalidomide and a proteasome inhibitor [ID4040]

  • Discontinued
  • GID-TA10926

Documents

Documents created during the development process.

Notes